Physical and biological studies on DNA/anti-DNA immune complex formed in vitro

Cytotechnology

Volumn 25, Issue 1-3, 1997, Pages 165-171

  Gao, Yuehua ^a   Wang, Pichao ^a   Tajima, Atsushi ^a   Matsumura, Masatoshi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Anti DNA antibody; Complement receptor; Immune complex; NZB W mice; SLE

Indexed keywords

EID: 0031415982     PISSN: 09209069     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1007926809023     Document Type: Conference Paper

References (25)

1. Agnello V and Mitamura T (1982) Evidence for detection of low molecular weight DNA-anti-DNA complexes in systemic lupus erythematosus. Arthritis Rheum 25: 788-792.
2. Bruneau CD, Edmonds JP, Hughes GRV and Aarden L (1977) Detection and characterization of DNA/anti-DNA complexes in a patient with systemic lupus erythematosus. Clin exp Immun 28: 433-436.
3. Chng HH, Fock KM, Chew CN, Guan R, Feng PH, Boey ML, Chee EN and Chua KL (1993) Hepatitis B virus infection in patients with systemic lupus erythematosus. Singapore Med J 34: 325-326.
4. Cornacoff JB, Hebert LA, Smead WL, Van Aman ME, Birminghan DJ and Waxman FJ (1883) Primate erythrocyte-immune complex-clearing mechanism. J clin Invest 71: 236-247.
5. Davies KA, Hird V, Stewart S, Sivolapenko GB, Jose P, Epenetos AA and Walport MJ (1990) A study of in vivo immune complex formation and clearance in man. J Immunol 144: 4613-4620.
6. Emlen W and Burdick F (1985) Clearance of Model DNA -anti-DNA immune complexes in mice. Arthritis Rheum 28: S40.
7. Emlen W, Carl V and Burdick G (1992) Mechanism of transfer of immune complexes from red blood cell CR1 to monocytes. Clin exp Immun 89: 8-17.
8. Finbloom DS and Plotz PH (1979) Studies of reticuloendothelial function in the mouse with model immune complexes. II. Serum clearance, tissue uptake, and reticuloendothelial saturation in NZB/W mice. J Immun 123: 1600-1603.
9. Horgan C and Emlen W (1987) Complement fixation by small, DNase-resistant DNA-anti-DNA immune complexes. Molec Immunol 24(2): 109-116.
10. Horgan C and Taylor RP (1984) Quantitative analyses of complement fixation in three immune complex systems. Immunology 52: 753-759.
11. Ikebe K, Gupta RC and Tan EM (1983) Characterization of DNA in polyethylene glycol precipitated immune complexes from serum of patients with systemic lupus erythematosus. Clin exp Immun 54: 169-177.
12. Koffler D, Schur PH and Kunkel HG (1967) Immunological studies concerning the nephritis of systemic lupus erythematosus. J exp Med 216: 607-611.
13. Koyama A, Kobayashi M, Suzuki S, Suzuki M, Yamaguchi N and Narita M (1991) Detection of DNA-bound immunoglobulins in patients with lupus nephritis, using monoclonal anti-DNA antibody. Clin exp Immun 85: 246-253.
14. Lennek R, Baldwin AS Jr, Waller SJ, Morley KW and Toylor RP (1981) Studies in the physical biochemistry and complement fixing properties of DNA/anti-DNA immune complexes. J Immun 127: 602-608.
15. Lu I, Cohen PR and Grossman ME (1995) Multiple dermatofibromas in a woman with HIV infection and systemic lupus erythematosus. J Amer Acad Dermatol 32: 901-903.
16. Mohan C and Datta SK (1995) Lupus: key pathogenic mechanisms and contributing factors. Clin Immuno Immunopatho 77: 209-220.
17. MoriokaT, Fujigaki Y, Batsford SR, Woitas R, Oite T, Shimizu F and Vogt A (1996) Anti-DNA antibody derived from a systemic lupus erythematosus (SLE) patient forms histone-DNA-anti-DNA complexes that bind to rat glomeruli in vivo. Clin Exp Immun 104: 92-96.
18. Negoro N, Inoue T, Okamura M, Amatsu K, Curd JG and Kanayama Y (1985) Direct measurement of plasma iC3b-neoantigen level in lupus nephritis by radioimmunoassay. Arthritis Rheum 28: S63.
19. Pereira AB, Theofilopoulos AN and Dixon FJ (1980) Detection and partial characterization of circulating immune complexes with solid-phase anti-C3. J Immun 125: 763-770.
20. Raptis L and Menard HA, (1980) Quantitaion and characterization of plasma DNA in normals and patients with systemic lupus erythematosus. J Clin Invest 66: 1391-1399.
21. Riley RL, Addis DJ and Taylor, RP (1980) Stability of DNA/anti-DNA complexes. II. Salt lability and avidity. J Immunol 124: 1-7.
22. Sagawa A, (1989) Significance of immunoadsorption therapy in patients with systemic lupus erythematosus. Therapeutic Plasma-phersis (VIII) 93-96.
23. Takahashi K, Yoshinoya S, Yoshizawa H and Miyamoto T (1987) Extracorporeal hydrophobic amino acid adsorbent therapy in rheumatoid arthritis. Clin Rheumatol 6: 553-563.
24. Taylor RP, Waller SJ, Haden C and Addis DJ (1980) Stability of DNA/anti-DNA complexes. III. Kinetic control of immune complex size. J Immun 124: 2571-2577.
25. Terman DS, Stewart I, Robinette J, Carr R and Harbeck R (1976) Specific removal of DNA antibodies in vivo with an extracorporeal immuno-absorbent. Clin Exp Immun 24: 231-237.